Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/221704
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNadal Rodríguez, Pau-
dc.contributor.authorHartung, Frederick-
dc.contributor.authorPedrola Teixell, Marina-
dc.contributor.authorCoomar, Seemon-
dc.contributor.authorDiaz-Moreno, Alejandro-
dc.contributor.authorHätälä, Anna M.-
dc.contributor.authorRolfes, Katharina M.-
dc.contributor.authorSánchez-Vera, Ismael-
dc.contributor.authorGil, Joan-
dc.contributor.authorMolins i Grau, Elies-
dc.contributor.authorViayna Gaza, Antonio-
dc.contributor.authorHanzl, Alexander-
dc.contributor.authorThomä, Nicolas H.-
dc.contributor.authorHaarmann-Stemmann, Thomas-
dc.contributor.authorLuque Garriga, F. Xavier-
dc.contributor.authorLavilla Grífols, Rodolfo-
dc.contributor.authorGhashghaei, Ouldouz-
dc.date.accessioned2025-06-23T06:58:29Z-
dc.date.available2025-06-23T06:58:29Z-
dc.date.issued2025-04-10-
dc.identifier.issn2374-7951-
dc.identifier.urihttps://hdl.handle.net/2445/221704-
dc.description.abstractA multidisciplinary platform is presented to address aryl hydrocarbon receptor (AhR) modulation. A rewired Yonemitsu multicomponent reaction with indole 2-carboxaldehydes and nucleophilic species was designed to access a family of 6-substituted indolocarbazoles. The conformational behavior of these compounds was examined to rationalize their axial chirality. In silico docking and molecular simulations highlighted key features implicated in their binding to AhR. Furthermore, the synthesis of linkable derivatives allowed the direct development of conjugated entities. Reporter gene and target gene expression analyses identified these novel structures as potent noncytotoxic activating AhR ligands, that can be extended to bifunctional molecules. The anti-inflammatory properties of these AhR agonists were assessed in interleukin-13 treated keratinocytes. Altogether, the synergistic research in synthetic and computational chemistry integrated with biological studies opens novel avenues toward understanding the biological roles of AhR and the development of targeted therapeutics.-
dc.format.extent13 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherAmerican Chemical Society-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1021/acscentsci.5c00194-
dc.relation.ispartofACS Central Science, 2025, num.11-
dc.relation.urihttps://doi.org/10.1021/acscentsci.5c00194-
dc.rightscc by (c) Pau Nadal Rodríguez, et al., 2025-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subject.classificationQuímica farmacèutica-
dc.subject.classificationSíntesi orgànica-
dc.subject.classificationCompostos heterocíclics-
dc.subject.otherPharmaceutical chemistry-
dc.subject.otherOrganic synthesis-
dc.subject.otherHeterocyclic compounds-
dc.titleA multicomponent reaction-based platform opens new avenues in Aryl Hydrocarbon Receptor modulation-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec758042-
dc.date.updated2025-06-23T06:58:29Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
892387.pdf7.25 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons